Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in puerto rican hispanics with dementia

Journal of Alzheimer's Disease

Volumn 33, Issue 4, 2013, Pages 1089-1095

  Arnold, Steven E ^a   Vega, Irving E ^b   Karlawish, Jason H ^a   Wolk, David A ^a   Nunez, Jessica ^a   Negron, Mirna ^a   Xie, Sharon X ^a   Wang, Li San ^a   Dubroff, Jacob G ^a   McCarty Wood, Elisabeth ^a   Trojanowski, John Q ^a   Van Deerlin, Vivianna ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

Author keywords

Age of onset; dementia; haplotype; presenilin

Indexed keywords

DNA; PRESENILIN 1;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; MALE; MICROSATELLITE MARKER; NEUROPATHOLOGY; NEUROPSYCHOLOGY; NUCLEOTIDE SEQUENCE; ONSET AGE; PRIORITY JOURNAL; PSYCHOMETRY;

EID: 84873659332     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-121570     Document Type: Article

References (34)

1. Clark CM, DeCarli C, Mungas D, Chui HI, Higdon R, Nunez J, Fernandez H, Negron M, Manly J, Ferris S, Perez A, Torres M, Ewbank D, Glosser G, van Belle G (2005) Earlier onset of Alzheimer disease symptoms in Latino individuals compared with Anglo individuals. Arch Neurol 62, 774-778
2. Livney MG, Clark CM, Karlawish JH, Cartmell S, Negron M, Nunez J, Xie SX, Entenza-Cabrera F, Vega IE, Arnold SE (2011) Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center. Am J Geriatr Psychiatry 19, 430-439
3. Ringman JM, Flores DL (2005) Earlier Alzheimer onset in Latino persons: Ethnic difference vs selection bias. Arch Neurol 62, 1786-1787
4. Lee JH, Barral S, Cheng R, Chacon I, Santana V,Williamson J, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Stern Y, Tycko B, Rogaeva E, Wakutani Y, Kawarai T, St George-Hyslop P, Mayeux R (2008) Age-At-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease. Neurogenetics 9, 51-60
5. Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, Rondon H, Lantigua RA, Medrano M, Torres M, Arawaka S, Rogaeva E, Song YQ, Sato C, Kawarai T, Fafel KC, Boss MA, Seltzer WK, Stern Y, St George-Hyslop P, TyckoB,MayeuxR(2001)Afounder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. JAMA 286, 2257-2263
6. Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, Richard E, Rogaev EI, Frommelt P, Sadovnick AD, Meschino W, Rockwood K, Boss MA, Mayeux R, St George-Hyslop P (2001) Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology 57, 621-625
7. Historical Society of Pennsylvania, Latino Philadelphia at a Glance, Accessed January 21, 2009, http://www.hsp.org/files/latinophiladelphiaataglance. pdff
8. Folstein MF, Folstein S, McHugh PR (1975) Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198
9. Chandler MJ, Lacritz LH, Hynan LS, Barnard HD, Allen G, Deschner M, Weiner MF, Cullum CM (2005) A total score for the CERAD neuropsychological battery. Neurology 65, 102-106
10. Clark CM, Ewbank DC (1996) Performance of the dementia severity rating scale: A caregiver questionnaire for rating severity in Alzheimer disease. Alzheimer Dis Assoc Disord 10, 31-39
11. Xie SX, Ewbank DC, Chittams J, Karlawish JHT, Arnold SE, Clark CM (2009) Rate of decline in Alzheimer's disease measured by a dementia severity rating scale. Alzheimer Dis Assoc Disord 23, 268-274
12. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, AdeyM, Lerer VO (1983) Development and validation of a Geriatric Depression Scale. J Psychiatr Res 17, 31-49
13. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, Lopez OL, DeKosky ST (2000) Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 12, 233-239
14. Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter W, Lee VM, Trojanowski JQ (2009) Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 65, 403-413
15. Shaw LM, Vanderstichele H, Knapik-Czajka M, Figurski M, Coart E, Blennow K, Soares H, Simon AJ, Lewczuk P, Dean RA, Siemers E, Potter W, Lee VM, Trojanowski JQ (2011) Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta Neuropathol 121, 597-609
16. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, Trojanowski JQ (2011) Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification. Neurobiol Aging 32 2322, e2319-e2327
17. Davatzikos C, Xu F, An Y, Fan Y, Resnick SM (2009) Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: The SPARE-AD index. Brain 132, 2026-2035
18. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM (2008) Individual patient diagnosis of AD and FTD via highdimensional pattern classification of MRI. Neuroimage 41, 1220-1227
19. Langbaum JB, Chen K, Lee W, Reschke C, Bandy D, Fleisher AS, Alexander GE, Foster NL,WeinerMW, Koeppe RA, Jagust WJ, Reiman EM (2009) Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage 45, 1107-1116
20. Newberg AB, Arnold SE,Wintering N, Rovner BW, Alavi A (2012) Initial clinical comparison of 18F-Florbetapir and 18FFDG PET in patients with Alzheimer disease and controls. J Nucl Med 53, 902-907
21. Nechiporuk A, Fain P, Kort E, Nee LE, Frommelt E, Polinsky RJ, Korenberg JR, Pulst SM (1993) Linkage of familial Alzheimer disease to chromosome 14 in two large early-onset pedigrees: Effects of marker allele frequencies on lod scores. Am J Med Genet 48, 63-66
22. Arnold SE, Han LY, Clark CM, Grossman M, Trojanowski JQ (2000) Quantitative neurohistological features of frontotemporal degeneration. Neurobiol Aging 21, 913-919
23. Geser F, Robinson JL, Malunda JA, Xie SX, Clark CM, Kwong LK, Moberg PJ, Moore EM, Van Deerlin VM, Lee VM, Arnold SE, Trojanowski JQ (2010) Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch Neurol 67, 1238-1250
24. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68, 978-989
25. Larner AJ, Doran M (2009) Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: An update. J Alzheimers Dis 17, 259-265
26. Leverenz JB, Fishel MA, Peskind ER, Montine TJ, Nochlin D, Steinbart E, Raskind MA, Schellenberg GD, Bird TD, Tsuang D (2006) Lewy body pathology in familial Alzheimer disease: Evidence for disease-And mutation-specific pathologic phenotype. Arch Neurol 63, 370-376
27. Shrimpton AE, Schelper RL, Linke RP, Hardy J, Crook R, Dickson DW, Ishizawa T, Davis RL (2007) A presenilin 1 mutation (L420R) in a family with early onset Alzheimer disease, seizures and cotton wool plaques, but not spastic paraparesis. Neuropathology 27, 228-232
28. Cercy SP, Sadowski MJ,Wisniewski T (2008) Prominent neuroleptic sensitivity in a case of early-onset Alzheimer disease due to presenilin-1 G206A mutation. Cogn Behav Neurol 21, 190-195
29. Mesulam M,Wicklund A, Johnson N, Rogalski E, Leger GC, Rademaker A,Weintraub S, Bigio EH (2008) Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol 63, 709-719
30. Jellinger KA, Attems J (2010) Is there pure vascular dementia in old age? J Neurol Sci 299, 150-154
31. Bonilla C, Shriver MD, Parra EJ, Jones A, Fernandez JR (2004) Ancestral proportions and their association with skin pigmentation and bone mineral density in Puerto Rican women from New York city. Hum Genet 115, 57-68
32. Carrion-Baralt JR, Suarez-Perez E, del Rio R, Moore K, Silverman JM (2010) Prevalence of dementia in Puerto Rican veterans is higher than in mainland U.S. veterans. J Am Geriatr Soc 58, 798-799
33. Kaiser Family Foundation (2011) Puerto Rico: Number of deaths due to Alzheimer's disease per 100,000 population, 2007, http://www.statehealthfacts. org/profileind.jsp?rgn=55&cat=2&ind=63
34. -2012) Colombia at the centre of preclinical AD research. Lancet Neurol 11, 567